Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 173

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model

Chou, Szu‐Yi, Lee, Yi‐Chao, Chen, Hui‐Mei, Chiang, Ming‐Chang, Lai, Hsing‐Lin, Chang, Hao‐Hung, Wu, Yi‐Chih, Sun, Chung‐Nan, Chien, Chen‐Li, Lin, Yow‐Sien, Wang, Shyi‐Chyi, Tung, Yu‐Ying, Chang, Chen, Chern, Yijuang·2005·Journal of Neurochemistry

Abstract

Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by a CAG trinucleotide expansion in exon 1 of the Huntingtin (Htt) gene. We show herein that in an HD transgenic mouse model (R6/2), daily administration of CGS21680 (CGS), an A 2A adenosine receptor (A 2A‐R)‐selective agonist, delayed the progressive deterioration of motor performance and prevented a reduction in brain weight. 3D‐µMRI analysis revealed that CGS reversed the enlarged ventricle‐to‐brain ratio of R6/2 mice, with particular improvements in the left and right ventricles. 1 H‐MRS showed that CGS significantly reduced the increased choline levels in the striatum. Immunohistochemical analyses further demonstrated that CGS reduced the size of ubiquitin‐positive neuronal intranuclear inclusions (NIIs) in the striatum of R6/2 mice and ameliorated mutant Htt aggregation in a striatal progenitor cell line overexpressing mutant Htt with expanded polyQ. Moreover, chronic CGS treatment normalized the elevated blood glucose levels and reduced the overactivation of a major metabolic sensor [5′AMP‐activated protein kinase (AMPK)] in the striatum of R6/2 mice. Since AMPK is a master switch for energy metabolism, modulation of energy dysfunction caused by the mutant Htt might contribute to the beneficial effects of CGS. Collectively, CGS is a potential drug candidate for the treatment of HD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2005.03029.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 173

Metadata

Authors
Chou, S., Lee, Y., Chen, H., Chiang, M., Lai, H., Chang, H., Wu, Y., Sun, C., Chien, C., Lin, Y., Wang, S., Tung, Y., Chang, C., & Chern, Y.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2005-03-02
Volume
93
Issue
2
Pages
310-320
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1579287598
Cited by
173
References
7
FWCI
2.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model. https://app.cochat.ai/papers/10.1111/j.1471-4159.2005.03029.x
The paper
Chou, S., Lee, Y., Chen, H., Chiang, M., Lai, H., Chang, H., Wu, Y., Sun, C., Chien, C., Lin, Y., Wang, S., Tung, Y., Chang, C., & Chern, Y. (2005). CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2005.03029.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.